facebook icon twitter icon rss icon
Text: Follow Us
Text: Working to win quality, affordable health care for all Marylanders

2018 Prescription Drug Affordability Initiative

Our 2018 Prescription Drug Affordability Initiative proposes the following:

  • TRANSPARENCY: Requiring prescription drug corporations to notify the public about expensive new drugs and large price increases for older drugs, and to justify those pricing decisions.


  • REASONABLE RATES: Creating a Maryland Prescription Drug Cost Review Commission in Maryland to examine the evidence and establish acceptable costs for drugs.


  • FAIRNESS: Preventing commercial managers of prescription drug plans from restricting what pharmacists can tell consumers about lower-cost drug options, as they sometimes do today.


Learn more and join our campaign today!